Stephanie Keller

Stephanie Keller, PhD, is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina (MUSC). She is affiliated with the College of Medicine and contributes to clinical and translational research in neuro-oncology. Her work is highlighted in initiatives like the GBM AGILE Trial, focusing on improving therapies for glioblastoma patients. Contact: kelleste@musc.edu.

Key research involvement includes the GBM AGILE Trial, a global effort to identify effective therapies for glioblastoma (GBM), which matches patients with experimental treatments like regorafenib. This trial emphasizes adaptive strategies to enhance survival outcomes.